PTE-PolarityTE® to Present at the DFCon 2018 Diabetic Foot G
Oct 5, 2018 12:26:01 GMT
miamianne67, icemandios, and 1 more like this
Post by c2crusher on Oct 5, 2018 12:26:01 GMT
PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE™
www.prnewswire.com/news-releases/polarityte-to-present-at-the-dfcon-2018-diabetic-foot-global-conference-on-clinical-outcomes-associated-with-skinte-300724967.html
SALT LAKE CITY, Oct. 5, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) announced that the Company will be presenting on its SkinTE technology and clinical outcomes at the 18th annual DFCon Diabetic Foot Global Conference on Thursday, October 11, 2018 in Houston, TX.
DFCon is the premier international, interdisciplinary diabetic foot conference in North America. In its 18th year, the course is designed for the wide spectrum of generalists and specialists who diagnose and manage the diabetic foot. Didactic talks, panel discussions, Q&A sessions, specialty symposia and workshops will delve into diagnostic and interventional strategies for diabetic foot ulcers and amputation prevention. Featuring a world-renowned international faculty, DFCon offers the opportunity to review state-of-the-art concepts and techniques. To learn more about DFCon: dfcon.com
The podium presentation entitled "Wound Care in a Box: Clinical Applications of a Novel Autologous Homologous Skin Construct for Full-Thickness Tissue Regeneration," will be given by the Chief Scientific Officer and VP of R&D of PolarityTE, Nikolai Sopko, MD, PhD. The presentation will highlight the platform technology and clinical outcomes data associated with SkinTE. PolarityTE is also sponsoring a lunch symposium on Friday, October 12 to discuss SkinTE with providers and researchers in attendance at the DFCon Global Conference.
"We are eager to present our translational technologies and clinical data associated with SkinTE at the 2018 DFCon Diabetic Foot Global Conference. The presentation provides us a tremendous opportunity to share our results and interact with the incredible thought leaders in the field focused on treating diabetic foot disease," commented Dr. Sopko.
Crusher
www.prnewswire.com/news-releases/polarityte-to-present-at-the-dfcon-2018-diabetic-foot-global-conference-on-clinical-outcomes-associated-with-skinte-300724967.html
SALT LAKE CITY, Oct. 5, 2018 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) announced that the Company will be presenting on its SkinTE technology and clinical outcomes at the 18th annual DFCon Diabetic Foot Global Conference on Thursday, October 11, 2018 in Houston, TX.
DFCon is the premier international, interdisciplinary diabetic foot conference in North America. In its 18th year, the course is designed for the wide spectrum of generalists and specialists who diagnose and manage the diabetic foot. Didactic talks, panel discussions, Q&A sessions, specialty symposia and workshops will delve into diagnostic and interventional strategies for diabetic foot ulcers and amputation prevention. Featuring a world-renowned international faculty, DFCon offers the opportunity to review state-of-the-art concepts and techniques. To learn more about DFCon: dfcon.com
The podium presentation entitled "Wound Care in a Box: Clinical Applications of a Novel Autologous Homologous Skin Construct for Full-Thickness Tissue Regeneration," will be given by the Chief Scientific Officer and VP of R&D of PolarityTE, Nikolai Sopko, MD, PhD. The presentation will highlight the platform technology and clinical outcomes data associated with SkinTE. PolarityTE is also sponsoring a lunch symposium on Friday, October 12 to discuss SkinTE with providers and researchers in attendance at the DFCon Global Conference.
"We are eager to present our translational technologies and clinical data associated with SkinTE at the 2018 DFCon Diabetic Foot Global Conference. The presentation provides us a tremendous opportunity to share our results and interact with the incredible thought leaders in the field focused on treating diabetic foot disease," commented Dr. Sopko.
Crusher